- Pathologic Processes868
- Tumors861
- Nervous System Diseases794
- Pathology636
- Mental Disorders615
Any
<10 miles
<30 miles
<50 miles
<70 miles
Filter Results
Condition
- Pathologic Processes868
- Tumors861
- Nervous System Diseases794
- Pathology636
- Mental Disorders615
Where are you looking?
How far are you willing to travel?Any
How old are you?
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
- HER2 negative
- PD-L1 positive
- ER positive
- HER2 positive
- EGFR positive
- EGFR negative
- PD-L1 negative
- PR positive
- ALK negative
- KRAS positive
- BRAF positive
- ER negative
- PR negative
- BRAF negative
- ALK positive
- ROS1 negative
- HLA positive
- CD20 positive
- BRCA1 positive
- p16 positive
- HLA-A positive
- MET positive
- BRCA2 positive
- HR positive
- PIK3CA positive
- IDH negative
- IDH positive
- MYC positive
- ROS1 positive
- TP53 positive
- RET positive
- p16 negative
- MET negative
- MSS positive
- ANA positive
- BCL2 positive
- BCR-ABL1 positive
- NRAS positive
- PALB2 positive
- CD19 positive
- HBsAg positive
- KRAS negative
- RET negative
- TP53 negative
- dMMR positive
- BCL6 positive
- COL7A1 positive
- HLA negative
- HLA-A negative
- HPV negative
- NTRK negative
- NTRK positive
- RB1 positive
- anti-dsDNA positive
- ctDNA positive
- ABCA4 positive
- BRCA positive
- BRCA1 negative
- BRCA2 negative
- CCND1 positive
- CFTR positive
- FGFR2 positive
- MGMT negative
- MMR negative
- MMR positive
- MSI-H positive
- NF1 positive
- PTEN positive
- RAS positive
- RB1 negative
- TROP2 negative
- TROP2 positive
- pMMR positive
- APOL1 positive
- APP positive
- C5 positive
- DLL3 positive
- FGFR3 positive
- FMR1 positive
- GPC3 positive
- HPV positive
- HRAS positive
- MDM2 positive
- MGMT positive
- MSI-H negative
- NF2 positive
- NRAS negative
- PSEN1 positive
- PSEN2 positive
- Philadelphia chromosome negative
- Philadelphia chromosome positive
- PiZZ positive
- RAS negative
- RF positive
- RHO positive
- dMMR negative
- p53 positive
- 11q negative
- 11q positive
- AKT negative
- ALPL positive
- ARID1A positive
- ATM positive
- Anti-PLA2R positive
- Aβ1-42 positive
- CD5 positive
- CLDN18.2 positive
- COL1A1 positive
- COL1A2 positive
- DMD positive
- EBV DNA positive
- EBV positive
- ER/PR positive
- Ex19del positive
- FLT3 negative
- FLT3 positive
- FOXO1 fusion negative
- GRN positive
- HBB positive
- HEXA positive
- HEXB positive
- HPV16 positive
- HR negative
- HbSS positive
- IGHV positive
- JAK2 positive
- KIT positive
- Ki67 positive
- L858R positive
- MLH1 positive
- MSH2 positive
- MSH6 positive
- MSI negative
- MSS negative
- MTAP positive
- NPM1 positive
- NY-ESO-1 positive
- PDE6A positive
- PDE6B positive
- PIK3CA negative
- PIK3CD positive
- PIK3R1 positive
- PKLR positive
- PMM2 positive
- PMS2 positive
- PTCH1 positive
- PTEN negative
- Ph positive
- RAF positive
- SMN1 positive
- SPINK5 positive
- T790M positive
- TTR positive
- UGT1A1 positive
- anti-AChR positive
- anti-MuSK positive
- anti-Ro autoantibodies positive
- anti-Ro/SSA positive
- anti-Sm positive
- anti-Smith positive
- dsDNA positive
- other sickle cell syndrome variants positive
- t(11;14) positive
- β-thalassemia positive
- 12 negative
- 12 positive
- 13q negative
- 13q positive
- 16p11.2 deletion positive
- 17p negative
- 17p positive
- 19q negative
- 19q positive
- 1p negative
- 1p positive
- 1p/19q co-deletion positive
- 1p/19q loss positive
- 1p36 deletion positive
- 22q13.3 deletion positive
- 46 XX karyotype positive
- 5q SMA positive
- 5q-autosomal recessive SMA positive
- AAVrh74 antibody titers negative
- ABL-class fusion positive
- ABL-class fusions positive
- ABO negative
- ABO positive
- ACD positive
- ACVR1 positive
- AChR positive
- AChR-Ab positive
- ADAMTS-13 negative
- ADAMTS-13 positive
- AFP positive
- AGXT positive
- AKT positive
- AKT1 positive
- APC positive
- APOE e4 positive
- AQP4 positive
- Gleason Score 10
- Gleason Score 6
- Gleason Score 7
- Gleason Score 8
- Gleason Score 9
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Stage IV
- Stage III
- Stage II
- Stage I
- 1927nm Fractional Thulium Laser Treatment
- Adjuvant Therapy (except reconstruction)
- Anti-Seizure Medications (up to 2 types)
- Any Treatment for Pancreatic Cancer
- At least one prior tumor-directed therapy
- Avoidance of Activities That Cause Joint Pain
- Beovu
- Biologic Anti-Neoplastic Agent
- Branch Retinal Vein Occlusion (BRVO)
- CD4+ > 350 cells/microliter for at least twelve months
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
5119 trials
Trials Without a Placebo
1
2
3
…50